In order to verify the synergistic anti-cancer effect of ACY-241 and PCI-34051 in wild-type p53 ovarian cancer, we used the CCK-8 assay and examined the combination index (CI) calculated based on the Chou and Talalay method (Figure 2A,B) [34]. The gene discussed is TP53; the disease is cancer.